The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
((1S,2S,4R)-4-(1-(4-bromophenyl)cyclobutylamino)-2-(thiophen-3-yl)cyclohexyl)(4-(5-chloropyridin-2-yl)piperazin-1-yl)methanone ID: ALA1940530
PubChem CID: 57398361
Max Phase: Preclinical
Molecular Formula: C30H34BrClN4OS
Molecular Weight: 614.05
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C([C@H]1CC[C@@H](NC2(c3ccc(Br)cc3)CCC2)C[C@@H]1c1ccsc1)N1CCN(c2ccc(Cl)cn2)CC1
Standard InChI: InChI=1S/C30H34BrClN4OS/c31-23-4-2-22(3-5-23)30(11-1-12-30)34-25-7-8-26(27(18-25)21-10-17-38-20-21)29(37)36-15-13-35(14-16-36)28-9-6-24(32)19-33-28/h2-6,9-10,17,19-20,25-27,34H,1,7-8,11-16,18H2/t25-,26+,27-/m1/s1
Standard InChI Key: ACVQDOWULDOCRR-KWXIBIRDSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
2.6833 -25.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0958 -26.5065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6791 -27.0940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2666 -26.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1667 -25.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1667 -26.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5454 -27.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2574 -26.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2574 -25.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5454 -25.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9730 -25.5063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4020 -25.5104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1156 -25.9307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8307 -25.5210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8336 -24.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1153 -24.2807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4031 -24.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5449 -27.9753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1225 -28.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1325 -29.2448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9575 -29.2448 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2123 -28.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8805 -27.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5956 -26.7437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8793 -27.9802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5991 -25.9155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3101 -25.5041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0264 -25.9141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0272 -26.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3117 -27.1560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7409 -25.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7376 -24.6697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4503 -24.2556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1666 -24.6665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1590 -25.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4527 -25.9061 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.8824 -24.2563 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.5487 -24.2838 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 18 2 0
7 18 1 6
9 11 1 1
6 23 1 1
11 1 1 0
23 24 1 0
1 2 1 0
23 25 2 0
24 26 1 0
1 12 1 0
2 3 1 0
12 13 2 0
3 4 1 0
13 14 1 0
24 30 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
4 1 1 0
14 15 2 0
31 32 2 0
5 6 1 0
32 33 1 0
15 16 1 0
33 34 2 0
5 10 1 0
34 35 1 0
16 17 2 0
35 36 2 0
36 31 1 0
28 31 1 0
17 12 1 0
34 37 1 0
18 19 1 0
15 38 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 614.05Molecular Weight (Monoisotopic): 612.1325AlogP: 6.83#Rotatable Bonds: 6Polar Surface Area: 48.47Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.49CX LogP: 6.72CX LogD: 4.65Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -1.55
References 1. Anthony Romero F, Hastings NB, Moningka R, Guo Z, Wang M, Di Salvo J, Lei Y, Trusca D, Deng Q, Tong V, Terebetski JL, Ball RG, Ujjainwalla F.. (2012) The discovery of potent antagonists of NPBWR1 (GPR7)., 22 (2): [PMID:22197390 ] [10.1016/j.bmcl.2011.11.126 ]